KPV Research & Studies
We track 20 published, PubMed-indexed studies for KPV, spanning 2000 to 2026. The research below includes 11 research articles, 8 reviews, 1 clinical trial.
These summaries are for educational purposes. Research findings, particularly from preclinical studies, may not translate to human outcomes. Always consult a qualified healthcare provider before making decisions based on this information.
11
Research Articles
8
Reviews
1
Clinical Trial
NLRP3 autophagic degradation disruption in melanocytes contributes to vitiligo development.
Research ArticleZeng K, Zhu Y, et al.|Cell Death Differ|2026
Inflammation-triggered self-immolative conjugates enable oral peptide delivery by overcoming gastrointestinal barriers.
Research ArticleCheng J, Wu P, et al.|Sci Adv|2026
Host defense peptides as a new drug lead to a strategy for inflammatory bowel disease.
ReviewRodrigues JM, Ferreira Leal AP, et al.|Drug Discov Today|2025
Exploring the Role of Tripeptides in Wound Healing and Skin Regeneration: A Comprehensive Review.
ReviewAdnan SB, Maarof M, et al.|Int J Med Sci|2025
Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway.
Research ArticleSung J, Ju SY, et al.|Tissue Cell|2025
KPV and RAPA Self-Assembled into Carrier-Free Nanodrugs for Vascular Calcification Therapy.
Research ArticleZhang L, Li D, et al.|Adv Healthc Mater|2024
PepT1-targeted nanodrug based on co-assembly of anti-inflammatory peptide and immunosuppressant for combined treatment of acute and chronic DSS-induced ColitiS.
Research ArticleZhang D, Jiang L, et al.|Front Pharmacol|2024
A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment.
Research ArticleMarotti V, Xu Y, et al.|Bioact Mater|2024
The Melanocortin System in Inflammatory Bowel Diseases: Insights into Its Mechanisms and Therapeutic Potentials.
ReviewGravina AG, Pellegrino R, et al.|Cells|2023
Trial of Erythropoietin for Hypoxic-Ischemic Encephalopathy in Newborns.
Clinical TrialWu YW, Comstock BA, et al.|N Engl J Med|2022
A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colon.
Research ArticleZhao Y, Xue P, et al.|Acta Biomater|2022
Skin-adaptive film dressing with smart-release of growth factors accelerated diabetic wound healing.
Research ArticleZhao Y, Huang L, et al.|Int J Biol Macromol|2022
Self-Cross-Linked Hydrogel of Cysteamine-Grafted γ-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats.
Research ArticleSun J, Xue P, et al.|ACS Biomater Sci Eng|2021
Novel anti-inflammatory and chondroprotective effects of the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride and human melanocortin MC3 receptor agonist PG-990 on lipopolysaccharide activated chondrocytes.
Research ArticleCan VC, Locke IC, et al.|Eur J Pharmacol|2020
Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin.
Research ArticlePawar K, Kolli CS, et al.|J Pharm Sci|2017
Terminal signal: anti-inflammatory effects of α-melanocyte-stimulating hormone related peptides beyond the pharmacophore.
ReviewBrzoska T, Böhm M, et al.|Adv Exp Med Biol|2010
Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases.
ReviewBrzoska T, Luger TA, et al.|Endocr Rev|2008
New insights into the functions of alpha-MSH and related peptides in the immune system.
ReviewLuger TA, Scholzen TE, et al.|Ann N Y Acad Sci|2003
The neuroimmunomodulatory peptide alpha-MSH.
ReviewIchiyama T, Sato S, et al.|Ann N Y Acad Sci|2000
The neuropeptide alpha-MSH in host defense.
ReviewCatania A, Cutuli M, et al.|Ann N Y Acad Sci|2000